Showing results (191-200 of 249) with videos related to

Sort By:
Pageof 25
Alzheimer'S Research & Therapy|February 14, 2026
Plasma ATN biomarkers across the alzheimer's disease continuum in a Chilean community- and clinic-based cohortPaulina Orellana, Fernando Henríquez, Felipe Cabral-Miranda, et al.
EJNMMI Research|April 1, 2025
Autoradiographic comparison between [11C]PiB and [18F]AZD4694 in human brain tissueAntonio Aliaga, Joseph Therriault, Kely Quispialaya, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
BiomarkersMarina P Gonçalves, Tevy Chan, Arthur C Macedo, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumPamela C L Ferreira, Guilherme Povala, Bruna Bellaver, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumPamela C L Ferreira, Tevy Chan, Bruna Bellaver, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 20, 2023
Equivalence of plasma p-tau217 with cerebrospinal fluid in the diagnosis of Alzheimer's diseaseJoseph Therriault, Stijn Servaes, Cécile Tissot, et al.
Brain : a Journal of Neurology|January 20, 2026
Clinical-biological Alzheimer's disease stage concordance: insights from cohorts and autopsy dataLydia Trudel, Joseph Therriault, Arthur C Macedo, et al.
Brain Communications|March 14, 2024
Predicting functional decline in aging and Alzheimer's disease with PET-based Braak stagingArthur C Macedo, Joseph Therriault, Cécile Tissot, et al.
Ebiomedicine|February 8, 2022
Comparing tau status determined via plasma pTau181, pTau231 and [18F]MK6240 tau-PETCécile Tissot, Joseph Therriault, Peter Kunach, et al.
JAMA Neurology|October 18, 2021
Differences Between Plasma and Cerebrospinal Fluid Glial Fibrillary Acidic Protein Levels Across the Alzheimer Disease ContinuumAndréa L Benedet, Marta Milà-Alomà, Agathe Vrillon, et al.
Pageof 25